Company Filing History:
3 out of 34 
2 out of 44 
1 out of 2 Years Active: 2012-2025
Title: Daumantas Matulis: Innovative Patents and Contributions to Biomedicine
Introduction:
Daumantas Matulis, a highly accomplished inventor and scientist hailing from Vilnius, Lithuania, has made significant contributions to the field of biomedicine through his innovative patents. With a keen focus on developing novel compounds and formulations, Matulis has played a crucial role in advancing pharmaceutical research. This article explores Matulis' latest patents, career highlights, and his collaborations with esteemed colleagues.
Latest Patents:
Matulis has been recognized for his groundbreaking work in developing selective inhibitors of carbonic anhydrase. His compounds, benzenesulfonamides, have been disclosed in the form of formulas (I) and (II). These compounds offer promising potential for their use as active ingredients in pharmaceutical formulations due to their ability to inhibit enzymes involved in disease progression. Alongside this, Matulis has also disclosed a glycerol-free formulation for reverse transcriptases, offering stability through a high salt concentration.
Career Highlights:
Throughout his career, Matulis has made significant strides in the field of biomedicine. Notably, he has contributed his expertise to renowned institutions such as Vilnius University and Thermo Fisher Scientific Baltics UAB. His unique approach to drug development and formulation has garnered widespread recognition and has opened up new avenues for research and innovation.
Collaborations:
Matulis has had the opportunity to collaborate with esteemed colleagues who share his passion for scientific exploration. He has worked alongside Virginija Dudutiene, a fellow scientist known for her expertise in molecular biology. Together, they have synergized their skills to develop cutting-edge pharmaceutical formulations. Additionally, Matulis has closely collaborated with Asta Zubriene, a respected researcher with a focus on enzymology. Their joint efforts have contributed to the advancement of knowledge and breakthroughs in the field.
Conclusion:
Daumantas Matulis has established himself as a pioneering force in the realm of biomedicine through his groundbreaking patents and contributions to the field. His developments in selective inhibitors of carbonic anhydrase and glycerol-free formulations for reverse transcriptases exemplify his commitment to improving pharmaceutical treatments. Matulis' collaboration with esteemed colleagues has further elevated his innovative work. With each new invention, he continues to push the boundaries of scientific research and inspire future generations of innovators in the domain of biomedicine.